RNF13 and metabolic dysfunction-associated steatotic liver disease: In the present study, we prove that RNF13 can control lipid deposition and inflammation response in NAFLD by regulating the level of two components of the innate immunity system, which are tripartite motif-containing 29 (TRIM29) and STING.